ArticlePloS one2025
Body mass index and critical care outcomes in hospitalized COVID-19 patients-A national cohort study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic caused significant global mortality. Obesity is associated with worse COVID-19 outcomes. This study examined the relationship between BMI, clinical interventions, and outcomes in hospitalized COVID-19 patients using pre-vaccine national data.
methodsWe conducted a retrospective cohort study using de-identified electronic health records from the HCA Healthcare database, comprising 149 hospitals across 18 U.S. states. Adults (≥18 years) hospitalized with confirmed SARS-CoV-2 infection between March 1 and December 31, 2022, were included. The primary outcome was a composite of in-hospital mortality or discharge to hospice, analyzed by BMI category. Secondary outcomes included inpatient mortality, need for mechanical ventilation or tracheostomy, duration of mechanical ventilation, and ICU (Intensive Care Unit) length of stay.
resultsOut of 38,321 hospital encounters, 21,996 met the inclusion criteria. Unadjusted analyses showed no significant differences in rates of all-cause mortality or hospice discharge across BMI categories. However, obese patients had higher rates of mechanical ventilation (7.8% vs. 4.6%, p < 0.001), tracheostomy placement (1.2% vs. 0.6%, p < 0.001), longer duration of mechanical ventilation (mean 11.5 ± 15.1 vs. 6.8 ± 8.7 days, p < 0.001), and longer ICU stays (8.3 ± 10.4 vs. 5.1 ± 6.4 days, p < 0.001) than normal BMI patients. In adjusted analyses controlling for age, sex, race, ethnicity, and comorbidities, obesity was independently associated with increased odds of all-cause mortality or hospice discharge (OR 1.29, 95% CI: 1.08-1.55, p < 0.05), inpatient mortality (OR 1.67, 95% CI: 1.34-2.08, p < 0.001), need for invasive mechanical ventilation (OR 1.55, 95% CI: 1.31-1.82, p < 0.001), and tracheostomy placement (OR 1.57, 95% CI: 1.03-2.41, p < 0.05). Obesity was a significant predictor of longer duration of mechanical ventilation (β = 3.67 days, 95% CI: 1.28-6.06, p < 0.001) and ICU stay (β = 2.90 days, 95% CI: 2.08-3.72, p < 0.001).
conclusionObesity was independently associated with increased risk of adverse clinical outcomes among hospitalized COVID-19 patients. These findings highlight the importance of BMI as a prognostic factor in acute COVID-19 management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.